Every Form 4 that Amerisafe (AMSF) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AMSF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMSF filings page.
AMERISAFE INC EVP–CSO Raymond F. Wise Jr. reported the conversion of 4,257 restricted stock units into an equal number of common shares on August 1, 2026. In connection with this event, 1,846 shares of common stock were disposed of at $29.04 per share to cover exercise-price or tax obligations. Following the conversion, Wise holds 9,878 restricted stock units from an original 14,188-unit grant made on August 1, 2023, which vests in four annual installments of 15%, 20%, 30%, and 35% beginning August 1, 2024.
GARCIA PHILIP A reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE, Inc. director Philip A. Garcia received an award of 2,340 shares of common stock on June 10, 2026. The shares were granted at $0.00 per share as a stock-based compensation award rather than a market purchase.
After this grant, Garcia directly holds 27,243 shares of AMERISAFE common stock. The new shares are subject to restrictions that will lapse at the time of the company’s 2027 annual meeting of shareholders, meaning they effectively vest at that meeting.
AMERISAFE director Jared A. Morris reported an equity award of 2,340 shares of common stock. The shares were granted at a price of $0.00 per share as a compensation-related award and are subject to restrictions that will lapse at the time of AMERISAFE's 2027 annual meeting of shareholders.
After this award, Morris holds 25,075 shares directly and 61,353 shares indirectly through the Jared Morris 1997 Trust. This filing reflects an acquisition of shares through a grant rather than an open-market purchase.
Greer Billy B reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE director Billy B. Greer received a grant of 2,340 shares of common stock on June 10, 2026. The shares were awarded at no cash cost per share as equity compensation and increased his directly held position to 8,861 shares.
The granted shares are subject to restrictions that will lapse at the time of AMERISAFE’s 2027 annual meeting of shareholders, meaning they effectively vest at that meeting if conditions are met.
TRAYNOR SEAN reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC director Sean Traynor received a stock award of 2,340 shares of common stock. The shares were granted at no cash cost as a compensation-related award and are subject to restrictions that will lapse at the time of the company’s 2027 annual meeting of shareholders.
Following this grant, Traynor directly holds a total of 18,326 AMERISAFE common shares, reflecting a routine increase in his equity stake tied to board service.
Roach Randy reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC director Randy Roach received a stock grant of 2,340 shares of common stock on June 10, 2026, at no cash cost per share. These shares are subject to restrictions that lapse at the company’s 2027 annual meeting of shareholders. After the grant, Roach directly holds 18,862 shares.
BROWN MICHAEL J reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC director Michael J. Brown received a grant of 2,340 shares of common stock on June 10, 2026. The shares were awarded at no cash cost to him as equity compensation.
The award is subject to restrictions that will lapse at the issuer's 2027 annual meeting of shareholders. Following this grant, Brown directly holds 15,761 shares of AMERISAFE common stock.
AMERISAFE, Inc. director Teri G. Fontenot reported an equity award of common stock. She acquired 2,340 shares of common stock at a stated price of $0.00 per share as a grant, not an open-market purchase.
The award is subject to restrictions that will lapse at the time of AMERISAFE's 2027 annual meeting of shareholders. After this grant, Fontenot directly holds 14,008 shares of AMERISAFE common stock.
AMERISAFE Inc. executive Guillermo A. Ramos, EVP and Chief Financial Officer, received a new equity award in the form of restricted stock units. On this grant, he acquired 2,970 restricted stock units, each representing a contingent right to receive one share of AMERISAFE common stock.
The restricted stock units fully vest on March 1, 2029, meaning he will receive the underlying shares only if the vesting conditions are satisfied through that date. Following this award, his directly held restricted stock units increased to 35,973, aligning his compensation further with long-term shareholder value.
Ramos Guillermo A reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC executive Guillermo A. Ramos, EVP and Chief Financial Officer, received a grant of 33,003 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of AMERISAFE common stock. Following this grant, he holds 33,003 restricted stock units directly.
The award vests over four years in annual installments of 15%, 20%, 30% and 35%, beginning on May 7, 2027, the first anniversary of the grant date. This structure links a significant portion of the executive’s compensation to the company’s long-term share performance and continued service.
Lestage Henry O IV reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC granted executive compensation in stock-based form. EVP and Chief Claims Officer Henry O. Lestage IV received 1,991 restricted stock units, each representing a contingent right to one share of common stock. These restricted stock units fully vest on March 1, 2029, if vesting conditions are met.
Following this grant, Lestage directly holds 24,112 shares or share-equivalents in total, indicating this is a routine, compensation-related equity award rather than a market purchase or sale.
Lestage Henry O IV reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC reported that EVP and Chief Claims Officer Henry O. Lestage IV received a grant of 22,121 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of AMERISAFE common stock, so the award ties his compensation to future share performance.
The RSUs vest in four annual installments: 15% on March 15, 2027, 20% on March 15, 2028, 30% on March 15, 2029, and 35% on March 15, 2030. Following this grant, his reported RSU holdings under this award total 22,121 units.
AMERISAFE Inc. executive vice president and Chief Risk Officer Vincent J. Gagliano received a grant of 6,392 shares of common stock on March 12, 2026 at no cost as equity compensation. To cover tax obligations, 2,708 shares were withheld at $32.92 per share, leaving him with 31,523 shares held directly after these transactions.
AMERISAFE INC executive Kathryn Shirley Housh reported routine equity compensation activity. On March 12, 2026, she received a grant of 5,905 shares of common stock at a price of 0.0000 per share as part of a grant or award.
On the same date, 2,501 shares were disposed of at 32.9200 per share to satisfy tax withholding obligations, a non-market transaction coded as a tax-liability payment. After these transactions, she directly holds 24,751 shares of AMERISAFE common stock.
AMERISAFE EVP–CSO Raymond F. Wise Jr. received a grant of 5,694 shares of common stock on March 12, 2026 at no cost, increasing his holdings to 9,029 shares before related taxes. To cover tax obligations, 2,468 shares were withheld at a price of $32.92 per share, leaving him with 6,561 shares held directly.
AMERISAFE INC President & CEO Janelle Frost reported routine equity compensation activity. She received a grant of 24,814 shares of common stock at no cost, increasing her direct holdings before tax actions. On the same date, 10,509 shares were disposed of to cover tax obligations at a price of $32.92 per share, which is not an open-market sale. After these transactions, she directly owns 129,531 shares of AMERISAFE common stock.
Wise Raymond F. Jr. reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE Inc. Executive Vice President and Chief Sales Officer Raymond F. Wise Jr. received a grant of 2,225 restricted stock units as equity compensation. Each unit represents a contingent right to receive one share of AMERISAFE common stock. Following this award, he now directly holds 14,135 restricted stock units. The newly granted units are scheduled to fully vest on March 1, 2029, meaning the underlying shares will only be delivered if the vesting conditions are satisfied over time.
AMERISAFE, Inc. executive Vincent J. Gagliano, EVP and Chief Risk Officer, received a grant of 2,386 restricted stock units. Each unit represents a contingent right to receive one share of Amerisafe common stock and the award fully vests on March 1, 2029.
Following this compensation grant, Gagliano holds 5,234 restricted stock units in total. The Form 4 classifies the transaction as a grant or award acquisition rather than an open-market purchase or sale of shares.
Shirley Kathryn Housh reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE INC executive Shirley Kathryn Housh, EVP and Chief Accounting Officer, received a grant of 2,118 restricted stock units. Each unit represents a contingent right to receive one share of Amerisafe common stock. Following this award, she holds 4,618 restricted stock units directly, which fully vest on March 1, 2029.
Frost G. Janelle reported acquisition or exercise transactions in this Form 4 filing.
AMERISAFE, Inc. President and CEO Janelle Frost received a grant of 8,326 restricted stock units, each representing a contingent right to one share of common stock. These units fully vest on March 1, 2029. Following this award, she holds 18,274 restricted stock units directly.
AMERISAFE INC executive Raymond F. Wise Jr., EVP – CSO, reported equity compensation activity involving restricted stock units and common shares. On March 1, 2026, 1,044 restricted stock units fully vested and were converted into 1,044 shares of common stock at a stated price of $0.00 per share. In a related move, 503 common shares were disposed of at $32.53 per share to satisfy tax-withholding obligations, leaving Wise with 3,335 directly owned common shares and 11,910 restricted stock units following the transactions.
AMERISAFE INC President & CEO Janelle Frost reported equity compensation activity. On March 1, 2026, 4,401 restricted stock units fully vested and were converted into 4,401 common shares at no cost. To cover taxes, 1,883 common shares were disposed of at $32.53 per share, leaving her with 115,226 directly held common shares.
AMERISAFE EVP – Chief Risk Officer Vincent J. Gagliano reported equity award activity involving restricted stock units and common shares. On March 1, 2026, 1,133 restricted stock units fully vested and were converted into 1,133 shares of common stock at a stated price of $0.00 per share.
Following this derivative exercise/conversion, his directly held restricted stock unit balance became 2,848 units and his common stock holdings rose to 28,370 shares. On the same date, 531 common shares at $32.53 per share were disposed of to satisfy tax obligations related to the award, leaving him with 27,839 directly held common shares.
AMERISAFE EVP and CAO Kathryn Housh reported routine equity compensation activity. On March 1, 2026, 1,047 restricted stock units fully vested and were converted into an equal number of common shares at no exercise price. To cover tax obligations, 478 common shares were disposed of at $32.53 per share through a tax-withholding transaction. After these moves, she directly held 21,347 shares of common stock and 2,500 restricted stock units.
AMERISAFE, Inc. insider trading report: The company’s Executive Vice President and Chief Financial Officer reported a sale of common stock. On 11/20/2025, the officer sold 1,247 shares of AMERISAFE common stock at a price of $40.21 per share in a single transaction. After this sale, the officer directly owns 2,539 shares of AMERISAFE common stock. This filing is reported on Form 4 for a single reporting person.
AMERISAFE (AMSF) reported an insider transaction by its EVP-CFO on a Form 4. On 11/07/2025, the officer sold 1,235 shares of common stock at a price of $40.74 per share.
Following the sale, the reporting person beneficially owns 3,786 shares, held directly. The filing reflects an open-market sale (code S) and confirms the person is an officer with the title EVP-CFO.